156 related articles for article (PubMed ID: 32580249)
1. Loss of efficacy of subsequent nonsurgical therapy after primary treatment failure in pediatric low-grade glioma patients-Report from the German SIOP-LGG 2004 cohort.
Kandels D; Pietsch T; Bison B; Warmuth-Metz M; Thomale UW; Kortmann RD; Timmermann B; Hernáiz Driever P; Witt O; Schmidt R; Gnekow AK
Int J Cancer; 2020 Dec; 147(12):3471-3489. PubMed ID: 32580249
[TBL] [Abstract][Full Text] [Related]
2. Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort.
Holzapfel J; Kandels D; Schmidt R; Pietsch T; Warmuth-Metz M; Bison B; Krauss J; Kortmann RD; Timmermann B; Thomale UW; Albert MH; Hernáiz Driever P; Witt O; Gnekow AK
Int J Cancer; 2020 Jun; 146(12):3385-3396. PubMed ID: 31613986
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.
Gnekow AK; Falkenstein F; von Hornstein S; Zwiener I; Berkefeld S; Bison B; Warmuth-Metz M; Driever PH; Soerensen N; Kortmann RD; Pietsch T; Faldum A
Neuro Oncol; 2012 Oct; 14(10):1265-84. PubMed ID: 22942186
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO-grade II-Report from the German/Swiss SIOP-LGG 2004 cohort.
Falkenstein F; Gessi M; Kandels D; Ng HK; Schmidt R; Warmuth-Metz M; Bison B; Krauss J; Kortmann RD; Timmermann B; Thomale UW; Albert MH; Pekrun A; Maaß E; Gnekow AK; Pietsch T
Int J Cancer; 2020 Oct; 147(8):2159-2175. PubMed ID: 32239677
[TBL] [Abstract][Full Text] [Related]
5. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
6. Natural history and management of low-grade glioma in NF-1 children.
Hernáiz Driever P; von Hornstein S; Pietsch T; Kortmann R; Warmuth-Metz M; Emser A; Gnekow AK
J Neurooncol; 2010 Nov; 100(2):199-207. PubMed ID: 20352473
[TBL] [Abstract][Full Text] [Related]
7. Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
Liu APY; Hastings C; Wu S; Bass JK; Heitzer AM; Ashford J; Vestal R; Hoehn ME; Ghazwani Y; Acharya S; Conklin HM; Boop F; Merchant TE; Gajjar A; Qaddoumi I
Cancer; 2019 Apr; 125(7):1163-1175. PubMed ID: 30620400
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
Nellan A; Wright E; Campbell K; Davies KD; Donson AM; Amani V; Judd A; Hemenway MS; Raybin J; Foreman NK; Rush S; Dorris K
J Neurooncol; 2020 Jul; 148(3):569-575. PubMed ID: 32506370
[TBL] [Abstract][Full Text] [Related]
9. Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.
Lassaletta A; Scheinemann K; Zelcer SM; Hukin J; Wilson BA; Jabado N; Carret AS; Lafay-Cousin L; Larouche V; Hawkins CE; Pond GR; Poskitt K; Keene D; Johnston DL; Eisenstat DD; Krishnatry R; Mistry M; Arnoldo A; Ramaswamy V; Huang A; Bartels U; Tabori U; Bouffet E
J Clin Oncol; 2016 Oct; 34(29):3537-3543. PubMed ID: 27573663
[TBL] [Abstract][Full Text] [Related]
10. High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group.
Perwein T; Benesch M; Kandels D; Pietsch T; Schmidt R; Quehenberger F; Bison B; Warmuth-Metz M; Timmermann B; Krauss J; Thomale UW; Kortmann RD; Driever PH; Gnekow AK
Neuro Oncol; 2021 Jul; 23(7):1148-1162. PubMed ID: 33346834
[TBL] [Abstract][Full Text] [Related]
11. Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: a report from the German multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG).
Mirow C; Pietsch T; Berkefeld S; Kwiecien R; Warmuth-Metz M; Falkenstein F; Diehl B; von Hornstein S; Gnekow AK
Pediatr Blood Cancer; 2014 Mar; 61(3):457-63. PubMed ID: 24039013
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
[TBL] [Abstract][Full Text] [Related]
13. Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.
Weiß S; Thomale UW; Schulz M; Kandels D; Schuhmann MU; El Damaty A; Krauss J; Driever PH; Witt O; Bison B; Pietsch T; Gnekow A; Simon M
Int J Cancer; 2023 Oct; 153(8):1487-1500. PubMed ID: 37260252
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.
Bouffet E; Jakacki R; Goldman S; Hargrave D; Hawkins C; Shroff M; Hukin J; Bartels U; Foreman N; Kellie S; Hilden J; Etzl M; Wilson B; Stephens D; Tabori U; Baruchel S
J Clin Oncol; 2012 Apr; 30(12):1358-63. PubMed ID: 22393086
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG 2004 cohort.
Thomale UW; Gnekow AK; Kandels D; Bison B; Hernáiz Driever P; Witt O; Pietsch T; Koch A; Capper D; Kortmann RD; Timmermann B; Harrabi S; Simon M; El Damaty A; Krauss J; Schuhmann MU; Aigner A
J Neurosurg Pediatr; 2022 Jul; ():1-14. PubMed ID: 35901673
[TBL] [Abstract][Full Text] [Related]
16. Neurosurgical treatment of pediatric low-grade midbrain tumors: a single consecutive institutional series of 15 patients.
Lundar T; Due-Tønnessen BJ; Egge A; Scheie D; Brandal P; Stensvold E; Due-Tønnessen P
J Neurosurg Pediatr; 2014 Dec; 14(6):598-603. PubMed ID: 25325421
[TBL] [Abstract][Full Text] [Related]
17. Current Salvage Treatment Strategies for Younger Children (<10 y of Age) With Progressive Low-grade Glioma After Initial Chemotherapy in North America: A Web-based Survey.
Moorman B; Barbour M; Huang MA
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e141-e145. PubMed ID: 33235141
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of centrally located low-grade glioma in children.
Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M
Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612
[TBL] [Abstract][Full Text] [Related]
19. Management of Primary Tectal Plate Low-Grade Glioma in Pediatric Patients: Results of the Multicenter Treatment Study SIOP-LGG 2004.
Kaufmann A; Gerber NU; Kandels D; Azizi AA; Schmidt R; Warmuth-Metz M; Pietsch T; Kortmann RD; Gnekow AK; Grotzer MA
Neuropediatrics; 2018 Oct; 49(5):314-323. PubMed ID: 29890518
[TBL] [Abstract][Full Text] [Related]
20. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
